Factors associated with positive and negative recommendations for cancer and non-cancer drugs for rare diseases in Canada

DOI: 10.1186/s13023-019-1104-7

Keywords: Rare diseases, Orphan drugs, Reimbursement review

Full-Text   Cite this paper   Add to My Lib

Abstract:

Description of variables included in the analyse

Full-Text